Dr. John Jefferies is an internationally recognized cardiologist specializing in cardiomyopathies, heart failure, genetics, heritable disease, artificial intelligence, and rare diseases. He is currently a Professor in the School of Public Health at the University of Memphis, the team cardiologist for the Memphis Grizzlies, and a Research Member of St Jude Children’s Research Hospital. Dr. Jeffries is also the immediate past Governor of the Tennessee Chapter of the American College of Cardiology and immediate President of the American Heart Association Mid-South region.

Dr. Jeffries is the lead Editor of two leading textbooks in cardiology and has authored or co-authored over 300 peer-reviewed manuscripts and book chapters. His research is funded by sources including the National Institutes of Health and multiple industry partners. He is actively involved in the advancement of innovative technologies including AI in healthcare, novel strategies for healthcare provision connectivity, precision medicine, diagnosis and management of rare diseases, and patient advocacy. Additionally, he has served as a Key Opinion Leader for over 30 national and international companies, has served on multiple Scientific Advisory Boards, and is a consultant to both privately held and publicly traded companies.

Dr. Jeffries completed his combined adult cardiology and pediatric training at the Baylor College of Medicine in Houston, Texas at the Texas Children's Hospital, and at the Texas Heart Institute. He received his MPH from the University of Kentucky with a major in Epidemiology, and his MBA from the Wharton Business School of the University of Pennsylvania with a dual major in Management and Entrepreneurship & Innovation.

Jay Saenz, MD, is a board-certified orthopedic surgeon and healthcare entrepreneur with over 19 years of experience in private practice. He is the Founder and President of Aethos Partners, a company dedicated to enhancing patient recovery through the integration of high-quality, innovative products into medical practices. Aethos Partners specializes in creating customized e-commerce platforms that align with the specific needs of individual practices.

His company, Aethos Partners, formerly engaged in a joint venture with Obento Health, a Y Combinator-backed startup specializing in digital marketing and patient education. He now continues to contribute to Obento Health as an advisor. Additionally, his expertise has been pivotal in driving business development at OrthoSouth, where he has played a key role in establishing strategic partnerships and elevating the quality of orthopedic care in local hospitals.

Dr. Saenz holds a Bachelor of Arts in Microbiology from the University of Arkansas and earned his Doctor of Medicine from the University of Arkansas for Medical Sciences. He completed his residency in Orthopedic Surgery at the University of Tennessee-Campbell Clinic and has been practicing in Memphis, TN, since 2005.

Dr. Tommy Wood is an Associate Professor of Neuroscience and Pediatrics at the University of Washington, where his research focuses on brain health including factors influencing long-term cognitive function and dementia risk.

Tommy earned his Bachelor’s degree in Biochemistry from the University of Cambridge, a medical degree from the University of Oxford, and a PhD in Physiology and Neuroscience from the University of Oslo. In addition to his academic work, Tommy has spent over a decade as a performance consultant for professional athletes, including Olympians and world champions.

He also hosts the Better Brain Fitness podcast, where he discusses strategies to prevent dementia and improve cognitive function. Tommy has appeared on The Drive by Dr. Peter Attia, sharing his expertise on dementia prevention and cognitive health.

Starting from his time at Omada Health, he has developed a diverse background in the digital health space where he has used his aging expertise in exercise, nutrition, and behavior change to focus on disease states such as diabetes, cardiovascular disease, and now Alzheimer’s and dementia.

As Neurotrack’s Chief Science Officer, Jordan leads the company’s scientific development and validation pipeline, while informing the company's business development/ partnerships. He also holds an academic dual-appointment at the University of Arkansas and has been authored on over 100 scientific publications. He is also the primary investigator on the DC-MARVEL project, which is the first study ever to investigate the effects of fully remote, digital health coaching on Alzheimer’s disease risk.

Jordan holds a PhD with specializations in exercise physiology, gerontology, and nutrition from the University of Arkansas.

Dr. Tanio is trained in internal medicine, brain health, longevity, and precision medicine. As co-founder of Rezilir Health, he leads a clinical team treating complex chronic conditions such as cognitive decline, neurodegenerative disorders, Long Covid, autoimmune diseases, ME/CFS, and environmentally acquired illnesses. His approach emphasizes identifying root causes and providing practical, evidence-based care, drawing from multiple medical disciplines and aligning with patients' values and preferences.

He holds a BA in Political Science from UCLA, an M.D. from UCSF, and an MBA from Wharton. He completed his residency and fellowship at the University of Pennsylvania, where he served as Chief Medical Resident and was a Robert Wood Johnson Clinical Scholar. Dr. Tanio is board certified in internal and functional medicine and has trained in several functional protocols.

He is a co-investigator in the Evanthea Research Study, which explores reversing cognitive decline, and leads studies on real-world outcomes for patients with cognitive decline and ME/CFS. His leadership roles include serving as Chief Medical Officer of JenCare, a multi-state group practice for Medicare Advantage patients, and as a Partner at McKinsey. He is also on the faculty at Johns Hopkins and Nova Southeastern University, and is a member of the Alpha Omega Alpha Medical Honor Society.